Selumetinib (AZD6244, ARRY-142886) J-BTC Phase 1 Study

Clinical trial NCT01949870 · TERMINATED

Trial details

NCT number: NCT01949870
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Inoperable Locally Advanced or Metastatic Biliary Tract Cancer

Start date: 2013-10-01
Primary completion: 2014-08-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.